LexDanaLexDanabeta
Inventor

Kenneth W. Dobie

Inventor
Del Mar, CA, US

Overview

75→
Patents
2003–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 75 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
A61KPreparations for medical, dental or toiletry purposes17%
Y02PClimate change mitigation technologies in the production or processing of goods8%
C07HSugars6%
C12YEnzymes6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
Y10TTechnical subjects covered by former us classification3%
A01KAnimal husbandry2%
C07KPeptides2%
PatentTitleYear
10,526,604Modulation of nuclear-retained RNA20209,856,473'Compositions and methods for modulation of LMNA expression'20189,624,496'Modulation of apolipoprotein C-III expression'20179,476,051'Antisense modulation of superoxide dismutase 1, soluble expression'20169,157,082'Modulation of apolipoprotein CIII (ApoCIII) expression'20159,139,831'Modulation of angiopoietin-like 3 expression'20158,993,529'Antisense modulation of superoxide dismutase 1, soluble expression'20158,921,331'Methods for slowing familial ALS disease progression'20148,883,997'Modulation of diacylglycerol acyltransferase 2 expression'20148,865,884'Antisense modulation of kinesin-like 1 expression'20148,853,178'Antisense modulation of PTP1B expression'20148,791,088'Compositions and methods for modulation of LMNA expression'20148,778,900'Modulation of eIF4E-BP1 expression'20148,765,700'Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions'20148,669,102'Modulation of prion expression'20148,642,753'Modulation of glucagon receptor expression'20148,637,484'Modulation of growth hormone receptor expression and insulin-like growth factor expression'20148,623,836'Modulation of growth hormone receptor expression and insulin-like growth factor expression'20148,614,310'Modulation of exportin 5 expression'20138,580,948'Modulation of forkhead box O1A expression'20138,530,439'Modulation of apolipoprotein C-III expression'20138,518,904'Modulation of STAT 6 expression'20138,513,400'Modulation of HIF1α and HIF2α expression'20138,470,795'Antisense modulation of kinesin-like 1 expression'20138,409,856'Compositions and their uses directed to gemin genes'20138,410,074'Modulation of eIF4E expression'20138,299,039'Modulation of growth hormone receptor expression and insulin-like growth factor expression'20128,299,041'Compositions and their uses directed to acetyl-CoA carboxylases'20128,258,109'Compositions and methods for modulation of LMNA expression'20128,258,289'Modulation of diacylglycerol acyltransferase 2 expression'20128,227,593'Modulation of forkhead box O1A expression'20128,217,017'Modulation of insulin like growth factor I receptor expression'20128,202,981'Compositions and their uses directed to PTPRU'20128,198,253'Compositions and their uses directed to HBXIP'20128,101,350'Modulation of exportin 5 expression'20128,067,386'Modulation of eIF4E-BP2 expression'20118,017,760'Antisense modulation of PTP1B expression'20117,981,868'Antisense modulation of p38 mitogen activated protein kinase expression'20117,960,358'Antisense modulation of stearoyl-CoA desaturase expression'20117,902,163'Antisense modulation of superoxide dismutase 1, soluble expression'20117,897,583'Compositions and their uses directed to PTPRU'20117,846,906'Modulation of growth hormone receptor expression and insulin-like growth factor expression'20107,825,235'Modulation of diacylglycerol acyltransferase 2 expression'20107,807,652'Modulation of eIF4E-BP2 expression'20107,807,649'Modulation of forkhead box O1A expression'20107,803,781'Modulation of growth hormone receptor expression and insulin-like growth factor expression'20107,799,764'Modulation of HIF1-beta expression'20107,759,479'Compositions and their uses directed to Gemin Genes'20107,750,141'Modulation of apolipoprotein c-III expression'20107,732,590'Modulation of diacylglycerol acyltransferase 2 expression'20107,718,628'Antisense modulation of kinesin-like 1 expression'20107,700,574'Modulation of RANKL expression'20107,618,947'Modulation of HIF-1 beta expression'20097,601,700'Modulation of eIF4E expression'20097,598,227'Modulation of apolipoprotein C-III expression'20097,585,968'Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)'20097,563,885'Modulation of Tudor-SN expression'20097,507,808'Modulation of endothelial lipase expression'20097,468,356'Modulation of insulin like growth factor I receptor expression'20087,468,431'Modulation of eIF4E-BP2 expression'20087,425,544'Modulation of eIF4E expression'20087,399,853'Modulation of glucagon receptor expression'20087,375,212'Modulation of Aurora B expression'20087,229,976'Modulation of forkhead box O1A expression'20077,217,572'Modulation of HIF1α and HIF2α expression'20077,199,107'Antisense modulation of kinesin-like 1 expression'20077,163,927'Antisense modulation of kinesin-like 1 expression'20077,144,999'Modulation of hypoxia-inducible factor 1 alpha expression'20067,132,530'Antisense modulation of superoxide dismutase 1, soluble expression'20067,033,830'Antisense modulation of MyD88 expression'20066,852,536'Antisense modulation of CD36L 1 expression'20056,828,151'Antisense modulation of hematopoietic cell protein tyrosine kinase expression'20046,743,909'Antisense modulation of PTPN12 expression'20046,716,627'Antisense modulation of mucin 1, transmembrane expression'20046,617,162'Antisense modulation of estrogen receptor alpha expression'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2015Patents assigned to ISIS PHARMACEUTICALS INC (68)· patent assignee history
2003–2018Based in Del Mar, CA, US· patent location history
2008–2014Patents assigned to ANTISENSE THERAPEUTICS LTD (7)· patent assignee history
2008–2012Based in Carlsbad, CA, US· patent location history
2009–2012Based in Delmar, CA, US· patent location history
2011–2015Patents assigned to DOBIE KENNETH W (28)· patent assignee history
2011–2014Patents assigned to BHANOT SANJAY (10)· patent assignee history
2012–2014Patents assigned to FREIER SUSAN M (9)· patent assignee history
2012Based in San Diego, CA, US· patent location history
2016–2020Based in Solana Beach, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ISIS PHARMACEUTICALS INC682003–2015
DOBIE KENNETH Wself282011–2015
BHANOT SANJAY102011–2014
FREIER SUSAN M92012–2014
ANTISENSE THERAPEUTICS LTD72008–2014
Locations
LocationPatentsSpan
Del Mar, California, US662003–2018
Solana Beach, California, US32016–2020
Carlsbad, California, US32008–2012
Delmar, California, US22009–2012
San Diego, California, US12012